Menu
Recruiting NCT07295782

The Assessment of Fibrin Clot Phenotype and Thrombin Generation in Women After Urogynecological Surgeries.

Observational Uterine Prolapse Urine Incontinence

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: determination of fibrin clot properties.
Who it may be relevant to
Registry conditions: Uterine Prolapse, Urine Incontinence. Basic parameters: 18 years — 70 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Poland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Fibrin Clot Properties and Thrombin Generation in Women After Urogynecological Surgery.

Overview

Determination of fibrin clot properties along with thrombin generation in women after urigynecological surgery.

Detailed description

Fibrin clot permeability and susceptibility to lysis along with thrombin generation

Interventions

  • Diagnostic test determination of fibrin clot properties
    Determination of fibre clot properties and thrombin generation in women with uterine prolapse/ urine incontinence before and after urogynecological surgery.

Primary outcome measures

  • fibrin clot phenotype [Time frame: December 2025 till May 2026]
  • Thrombin generation [Time frame: December 2025 till May 2026]

Eligibility criteria

Inclusion criteria

  • Age 18-70
  • treatment failure (pharmacotherapy) due to uterine prolapse or urine incontinence

Exclusion criteria

  • prolonged thromboprophylaxis
  • planned surgery other than due to urine incontinence/uterine prolapse
  • acquired or congenital thrombophilia

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

Poland · 1 center
  • Gynecological Endocrinology Department — Krakow

Identifiers

NCT: NCT07295782 · 1072.6120.315.2022

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗